Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is a leader in the medical technology industry, specifically in silicone breast implants, with increasing demand and potential market expansion through product developments and minimally invasive surgery techniques. Despite potential risks from competition and regulations, the company has a strong financial performance and a projected positive outlook for the coming years, specifically in the minimally invasive business and planned product expansions.

Bears say

Establishment Labs Hldgs is seeing a continued increase in Motiva usage, driven by factors such as growing patient demand, increased familiarity and positive outcomes from physicians, and long-term safety data. As a result, it is expected to capture a significant share of the market from competitors such as Allergan and Mentor. Their continuous improvement in surveys and increased number of accounts shows promising growth potential, justifying a Buy rating and a $90 price target. Risks include economic downturn, competition, and potential complications, among others.

ESTA has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Strong Buy based on their latest research and market trends.

According to 8 analysts, ESTA has a Strong Buy consensus rating as of Sep 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.